We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+2.71%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$10.1B
AUM Growth
+$137M
Cap. Flow
+$105M
Cap. Flow %
1.04%
Top 10 Hldgs %
27.88%
Holding
173
New
17
Increased
64
Reduced
61
Closed
5

Top Buys

Rank Stock Value
1
AMED
Amedisys
AMED
+$92.7M
2
PGNY icon
Progyny
PGNY
+$45.5M
3
PRVA icon
Privia Health
PRVA
+$44.6M
4
SQSP
Squarespace, Inc.
SQSP
+$42.6M
5
TDUP icon
ThredUp
TDUP
+$40.4M

Sector Composition

Rank Sector Weight
1 Technology 38.01%
2 Healthcare 23%
3 Industrials 15.49%
4 Consumer Discretionary 8.61%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPO icon
26
Exponent
EXPO
$3.19B
$124M 1.22%
1,058,614
+35,083
+3% +$4.12M
TECH icon
27
Bio-Techne
TECH
$11.2B
$121M 1.2%
937,556
+23,488
+3% +$2.88M
GDYN icon
28
Grid Dynamics Holdings
GDYN
$569M
$117M 1.16%
3,088,803
+117,281
+4% +$4.05M
DHR icon
29
Danaher
DHR
$138B
$117M 1.16%
401,421
-10,622
-3% -$2.93M
CERT icon
30
Certara
CERT
$1.26B
$116M 1.15%
4,088,873
+1,200,478
+42% +$40.4M
AMN icon
31
AMN Healthcare
AMN
$1.35B
$109M 1.08%
891,615
+28,847
+3% +$3.2M
INFO
32
DELISTED
IHS Markit Ltd. Common Shares
INFO
$109M 1.07%
817,360
-24,864
-3% -$3.17M
CRM icon
33
Salesforce
CRM
$154B
$104M 1.03%
409,960
-10,901
-3% -$3.06M
VEEV icon
34
Veeva Systems
VEEV
$33.8B
$99.3M 0.98%
388,655
-10,627
-3% -$3.09M
UNH icon
35
UnitedHealth
UNH
$382B
$99.2M 0.98%
197,591
-5,615
-3% -$2.54M
AVLR
36
DELISTED
Avalara, Inc.
AVLR
$99.1M 0.98%
767,663
+5,998
+0.8% +$936K
NVDA icon
37
NVIDIA
NVDA
$4.6T
$98.4M 0.97%
3,344,790
-1,190,840
-26% -$32.8M
ADI icon
38
Analog Devices
ADI
$172B
$98.1M 0.97%
558,351
-13,888
-2% -$2.46M
SBUX icon
39
Starbucks
SBUX
$119B
$97.8M 0.97%
835,763
-21,250
-2% -$2.4M
GWRE icon
40
Guidewire Software
GWRE
$13.9B
$92.4M 0.91%
813,483
+1,538
+0.2% +$182K
IDXX icon
41
Idexx Laboratories
IDXX
$44.9B
$91.6M 0.91%
139,178
-3,684
-3% -$2.31M
NATI
42
DELISTED
National Instruments Corp
NATI
$89.7M 0.89%
2,053,931
-847,771
-29% -$36M
FVRR icon
43
Fiverr
FVRR
$331M
$86M 0.85%
756,719
+212,015
+39% +$33.1M
NOW icon
44
ServiceNow
NOW
$120B
$84.5M 0.84%
650,750
-15,350
-2% -$2.02M
GDDY icon
45
GoDaddy
GDDY
$13.9B
$84.3M 0.83%
992,916
+22,752
+2% +$1.63M
WSC icon
46
WillScot Mobile Mini Holdings
WSC
$4.37B
$78.1M 0.77%
1,912,260
+75,037
+4% +$2.77M
PPLI
47
People Inc
PPLI
$3.12B
$77.6M 0.77%
723,565
-7,317
-1% -$825K
GOOGL icon
48
Alphabet (Google) Class A
GOOGL
$4.12T
$76.7M 0.76%
529,560
-9,060
-2% -$1.3M
JKHY icon
49
Jack Henry & Associates
JKHY
$11.4B
$70.2M 0.69%
420,280
-25,175
-6% -$4.07M
TWOU
50
DELISTED
2U Inc
TWOU
$66.8M 0.66%
110,866
-4,790
-4% -$3.82M

Similar funds

Riverbridge Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Riverbridge Partners held 173 positions worth $10.1B, up 1.4% from $9.97B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Riverbridge Partners's Q4 2021 filing shows 17 new, 64 increased, 61 reduced and 5 closed positions. Its largest new stake was Progyny: 812,333 shares worth $40.9M. The largest sale was Gentex, an estimated $91.3M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 39% a quarter earlier, followed by Healthcare and Industrials.

  • Riverbridge Partners's largest Q4 2021 buy was Progyny: 812,333 shares worth $40.9M.
  • Riverbridge Partners added most to Amedisys in Q4 2021, an estimated $92.7M increase.
  • Riverbridge Partners's biggest Q4 2021 reduction was Gentex, cutting an estimated $91.3M.
  • Riverbridge Partners fully exited Maximus in Q4 2021, selling an estimated $39.6M.
  • Riverbridge Partners's ten largest holdings make up 28% of its $10.1B portfolio in Q4 2021.
  • Riverbridge Partners opened 17 new positions and closed 5 in Q4 2021.
  • Riverbridge Partners's portfolio value rose 1.4% quarter-over-quarter to $10.1B.

Based on Riverbridge Partners's 13F filing for Q4 2021, filed 14 Jan 2022.